1Anandan C,Nurmatov U, Van Schayck OC, et al. Is the prevalence of asthma declining? Systematic review of epidemiological studies. Allergy ,2010,65 : 152-67.
3Kaiser H. Cortison therapy today. Wien Klin Wochenschr, 2003, 115:6-21.
4Sasaki A, Ouchi K, Makata H, et al. The effect of inhaled corticosteroids on Chlamydophila pneumoniae and Mycoplasma pneumoniae infection in children with bronchial asthma. J Infect Chemother,2009,15:99-103.
5Mullaoglu S, Turktas H, Kokturk N, et al. Esophageal candidiasis and Candida colonization in asthma patients on inhaled steroids. Allergy Asthma Proc ,2007,28:544-549.
6Sekine A, Hagiwara E, Ogura T, et al. A case of pulmonary Mycobacterium avium infection presenting multiple nodules with substantial difference in 18F-fluorodeoxyglucose uptake. Nihon Kokyuki Gakkai Zasshi ,2009,47:575-580.
7Christensson C, Thoren A, Lindberg B, et al. Safety of inhaled budesonide:clinical manifestations of systemic corticosteroid-related adverse effects. Drug Saf,2008 ,31:965-988.
8Gluck PA, Gluck JC. A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr Med Res Opin, 2005,21 : 1075-1084.
9Fal AM, Kopec A. Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment. Pneumomol Alergol Pol,2010,78:68-73.
10Polosa R. Critical appraisal of antileukotriene use in asthma management. Curr Opin Pulm Med,2007,13:24-30.
